CYTH – cyclo therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CYTH

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

8/27

09:16 am

cyth

Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "hold" rating re-affirmed by analysts at Maxim Group.

Medium Report

Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "hold" rating re-affirmed by analysts at Maxim Group.

Report

8/27

08:31 am

cyth

Rating for CYTH

Medium Report

Rating for CYTH

Report

8/26

06:05 am

cyth

Rating for CYTH

Medium Report

Rating for CYTH

Report

8/23

08:09 am

cyth

Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $0.95 price target on the stock, down previously from $3.00.

High Report

Cyclo Therapeutics, Inc. (NASDAQ: CYTH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $0.95 price target on the stock, down previously from $3.00.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.